ClinicalTrials.gov
public full text
Public Domain
Influence of Pioglitazone for Renal Transplant Function in Diabetics
The purpose of this study is to test whether pioglitazone is able to prevent the progression of diabetic nephropathy in kidney transplant recipients with diabetes mellitus.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Inhibitors of sodium-glucose co-transporters in the treatment of diabetic nephropathy and chronic kidney disease: A narrative review#1305843
- Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease#890569
- Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients#1171178
- Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients#1365232
- An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria#1281434
Record · ID 1228724
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive